[11C]-(7bR,10aR)-2,3,4,7b,8,9,10,10a-octahydro-1H-cyclopenta[b][1,4]diazepino[6,7,1-hi]indole

ID: ALA3126690

Chembl Id: CHEMBL3126690

PubChem CID: 76314636

Max Phase: Preclinical

Molecular Formula: C14H18N2

Molecular Weight: 214.31

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  c1cc2c3c(c1)[C@H]1CCC[C@H]1N3CCN[11CH2]2

Standard InChI:  InChI=1S/C14H18N2/c1-3-10-9-15-7-8-16-13-6-2-4-11(13)12(5-1)14(10)16/h1,3,5,11,13,15H,2,4,6-9H2/t11-,13-/m1/s1/i9-1

Standard InChI Key:  XOSKJKGKWRIMGV-AZLXSBFYSA-N

Associated Targets(non-human)

Brain (4256 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brain (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 214.31Molecular Weight (Monoisotopic): 214.1470AlogP: 2.25#Rotatable Bonds: 0
Polar Surface Area: 15.27Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.89CX LogP: 2.35CX LogD: 0.85
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.71Np Likeness Score: 0.20

References

1. Neelamegam R, Hellenbrand T, Schroeder FA, Wang C, Hooker JM..  (2014)  Imaging evaluation of 5HT2C agonists, [(11)C]WAY-163909 and [(11)C]vabicaserin, formed by Pictet-Spengler cyclization.,  57  (4): [PMID:24491146] [10.1021/jm401802f]

Source